These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 24402097)
1. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury. Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin pretreatment attenuates acute renal tubular injury against ischemia-reperfusion by restoring transient receptor potential channel-6 expression and function in collecting ducts. Shen S; Jin Y; Li W; Liu X; Zhang T; Xia W; Wang Y; Ma K Crit Care Med; 2014 Oct; 42(10):e663-72. PubMed ID: 25072760 [TBL] [Abstract][Full Text] [Related]
3. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model. Hochhauser E; Pappo O; Ribakovsky E; Ravid A; Kurtzwald E; Cheporko Y; Lelchuk S; Ben-Ari Z Apoptosis; 2008 Jan; 13(1):77-86. PubMed ID: 18085440 [TBL] [Abstract][Full Text] [Related]
5. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition. Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular heme oxygenase-1: a potential mechanism of erythropoietin-mediated protection after liver ischemia-reperfusion injury. Riehle KJ; Hoagland V; Benz W; Campbell JS; Liggitt DH; Langdale LA Shock; 2014 Nov; 42(5):424-31. PubMed ID: 25004066 [TBL] [Abstract][Full Text] [Related]
8. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats. Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Sølling C; Christensen AT; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK Acta Anaesthesiol Scand; 2011 Feb; 55(2):185-95. PubMed ID: 21226860 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat. Sepodes B; Maio R; Pinto R; Sharples E; Oliveira P; McDonald M; Yaqoob M; Thiemermann C; Mota-Filipe H Transpl Int; 2006 Nov; 19(11):919-26. PubMed ID: 17018128 [TBL] [Abstract][Full Text] [Related]
11. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling. Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation. Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412 [TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin through the placenta barrier and fetal blood-brain barrier with transient uteroplacental ischemia]. Ma YS; Zhou J; Liu H; Du Y; Lin XM Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):687-9, 724. PubMed ID: 23230739 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain. Yamada M; Burke C; Colditz P; Johnson DW; Gobe GC J Pathol; 2011 May; 224(1):101-9. PubMed ID: 21404277 [TBL] [Abstract][Full Text] [Related]
15. The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. Kiris I; Kapan S; Kilbas A; Yilmaz N; Altuntaş I; Karahan N; Okutan H J Surg Res; 2008 Oct; 149(2):206-13. PubMed ID: 18639893 [TBL] [Abstract][Full Text] [Related]
16. Preischemic Administration of Nonexpanded Adipose Stromal Vascular Fraction Attenuates Acute Renal Ischemia/Reperfusion Injury and Fibrosis. Zhou L; Xu L; Shen J; Song Q; Wu R; Ge Y; Xin H; Zhu J; Wu J; Jia R Stem Cells Transl Med; 2016 Sep; 5(9):1277-88. PubMed ID: 27365485 [TBL] [Abstract][Full Text] [Related]
17. Erythropoietin Ameliorates Ischemia/Reperfusion-Induced Acute Kidney Injury via Inflammasome Suppression in Mice. Kwak J; Kim JH; Jang HN; Jung MH; Cho HS; Chang SH; Kim HJ Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414157 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin attenuates neuronal apoptosis and cognitive defects via JAK2/STAT3 signaling in experimental endotoxemia. Zhou TF; Yu JG J Surg Res; 2013 Jul; 183(1):304-12. PubMed ID: 23236988 [TBL] [Abstract][Full Text] [Related]
19. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271 [TBL] [Abstract][Full Text] [Related]
20. Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment. Liu NM; Tian J; Wang WW; Han GF; Cheng J; Huang J; Zhang JY Genet Mol Res; 2013 Feb; 12(4):6477-87. PubMed ID: 23479159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]